• Increase font size
  • Default font size
  • Decrease font size
You are here: News

Latest News

Title Filter 
Display # 
# Article Title Date
1 Eribis appoints new members in the Board of Directors as well as new Management members 2011-02-14
2 Publication in the European Journal of Pharmacology 2010-11-22
3 Karolinska Development re-invests 300,000 € in Eribis 2010-10-01
4 Pilot dose responce study in pigs performed at Salhgrenska University Hospital 2010-07-16
5 New animal study to begin in collaboration with Prof. Garrett Gross 2010-06-20
6 Poster accepted at ESC congress in Stockholm 2010-05-12
7 Meet Eribis at these upcoming events 2009-08-28
8 New scientific advisor appointed 2009-06-01
9 Eribis presented in SwedenToday 2009-04-30
10 Eribis at BioConvention Atlanta 2009-04-25
11 GMP batch of EP peptide 94 produced and quality assured 2009-04-15
12 Eribis Candidate Drug (EP94) shows significant results 2009-04-01
13 Regional patent applications submitted 2009-02-28
14 Eribis appoints Scientific Advisory Board 2008-09-01
15 Second cash injection 2008-06-30
16 PCT application submitted 2007-08-17
17 National patent application submitted in Sweden 2006-08-17
18 New Medical Advisor assigned 2006-08-01
19 Collaboration with Karolinska Development AB 2006-06-01
  • Home
  • The Company
  • Science
  • The Products
  • Investor Relations
  • News
    • Pressreleases
  • Contact
Copyright © Eribis Pharmaceuticals.  Developed by dreamforce.se.  This web site uses cookies. Read more.